SSA
ETON icon

Schonfeld Strategic Advisors’s Eton Pharmaceutcials ETON Stock Holding History

Schonfeld Strategic Advisors’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-24,213
Closed -$314K – 2176
2025
Q1 		$314K Sell
24,213
-65,451
-73% -$989K ﹤0.01% 1766
2024
Q4 		$1.19M Buy
89,664
+72,464
+421% +$735K 0.01% 1038
2024
Q3 		$103K Sell
17,200
-33,717
-66% -$143K ﹤0.01% 1865
2024
Q2 		$168K Sell
50,917
-45,952
-47% -$161K ﹤0.01% 1832
2024
Q1 		$363K Buy
96,869
+38,559
+66% +$168K ﹤0.01% 1577
2023
Q4 		$255K Buy
58,310
+14,710
+34% +$59K ﹤0.01% 1474
2023
Q3 		$182K Buy
+43,600
New +$168K ﹤0.01% 1428

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Schonfeld Strategic Advisors's ETON Position: Q2 2025 in Review

Schonfeld Strategic Advisors sold out of Eton Pharmaceutcials (ETON) in Q2 2025, closing a stake of 24,213 shares — an estimated $314K sold.

Schonfeld Strategic Advisors first reported a position in ETON in Q3 2023 and held it in 7 quarters. The position peaked at $1.19M in Q4 2024. 87 funds tracked by Wall St. Rank hold ETON as of Q2 2025.

  • Schonfeld Strategic Advisors reported no remaining Eton Pharmaceutcials position as of Q2 2025 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 24,213 Eton Pharmaceutcials shares in Q2 2025, an estimated $314K.
  • Schonfeld Strategic Advisors first reported a position in Eton Pharmaceutcials in Q3 2023 and held it in 7 quarters.
  • Schonfeld Strategic Advisors's Eton Pharmaceutcials position peaked at $1.19M in Q4 2024.
  • 87 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.